145 related articles for article (PubMed ID: 23346199)
1. Triptolide Transcriptionally Represses HER2 in Ovarian Cancer Cells by Targeting NF-κB.
Ou CC; Chen YW; Hsu SC; Sytwu HK; Loh SH; Li JW; Liu JY
Evid Based Complement Alternat Med; 2012; 2012():350239. PubMed ID: 23346199
[TBL] [Abstract][Full Text] [Related]
2. TPL Inhibits the Invasion and Migration of Drug-Resistant Ovarian Cancer by Targeting the PI3K/AKT/NF-κB-Signaling Pathway to Inhibit the Polarization of M2 TAMs.
Le F; Yang L; Han Y; Zhong Y; Zhan F; Feng Y; Hu H; Chen T; Tan B
Front Oncol; 2021; 11():704001. PubMed ID: 34381726
[TBL] [Abstract][Full Text] [Related]
3. Triptolide inhibits the proliferation of cells from lymphocytic leukemic cell lines in association with downregulation of NF-κB activity and miR-16-1*.
Meng HT; Zhu L; Ni WM; You LS; Jin J; Qian WB
Acta Pharmacol Sin; 2011 Apr; 32(4):503-11. PubMed ID: 21441948
[TBL] [Abstract][Full Text] [Related]
4. Triptolide enhances the sensitivity of pancreatic cancer PANC-1 cells to gemcitabine by inhibiting TLR4/NF-κB signaling.
Ma JX; Sun YL; Yu Y; Zhang J; Wu HY; Yu XF
Am J Transl Res; 2019; 11(6):3750-3760. PubMed ID: 31312385
[TBL] [Abstract][Full Text] [Related]
5. Triptolide avoids cisplatin resistance and induces apoptosis via the reactive oxygen species/nuclear factor-κB pathway in SKOV3
Zhong YY; Chen HP; Tan BZ; Yu HH; Huang XS
Oncol Lett; 2013 Oct; 6(4):1084-1092. PubMed ID: 24137468
[TBL] [Abstract][Full Text] [Related]
6. Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.
Sai K; Li WY; Chen YS; Wang J; Guan S; Yang QY; Guo CC; Mou YG; Li WP; Chen ZP
Am J Chin Med; 2014; 42(2):485-503. PubMed ID: 24707876
[TBL] [Abstract][Full Text] [Related]
7. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.
Tsatsanis C; Patriotis C; Tsichlis PN
Oncogene; 1998 Nov; 17(20):2609-18. PubMed ID: 9840924
[TBL] [Abstract][Full Text] [Related]
8. The oncogenic protein kinase Tpl-2/Cot contributes to Epstein-Barr virus-encoded latent infection membrane protein 1-induced NF-kappaB signaling downstream of TRAF2.
Eliopoulos AG; Davies C; Blake SS; Murray P; Najafipour S; Tsichlis PN; Young LS
J Virol; 2002 May; 76(9):4567-79. PubMed ID: 11932422
[TBL] [Abstract][Full Text] [Related]
9. Triptolide inhibits the proliferation and migration of medulloblastoma Daoy cells by upregulation of microRNA-138.
Zhang H; Li H; Liu Z; Ge A; Guo E; Liu S; Chen Z
J Cell Biochem; 2018 Dec; 119(12):9866-9877. PubMed ID: 30156009
[TBL] [Abstract][Full Text] [Related]
10. Discovery of potential targets of Triptolide through inverse docking in ovarian cancer cells.
Wu Q; Bao G; Pan Y; Qian X; Gao F
PeerJ; 2020; 8():e8620. PubMed ID: 32219016
[TBL] [Abstract][Full Text] [Related]
11. Triptolide downregulates human GD3 synthase (hST8Sia I) gene expression in SK-MEL-2 human melanoma cells.
Kwon HY; Kim SJ; Kim CH; Son SW; Kim KS; Lee JH; Do SI; Lee YC
Exp Mol Med; 2010 Dec; 42(12):849-55. PubMed ID: 21072003
[TBL] [Abstract][Full Text] [Related]
12. Role of triptolide as an adjunct chemotherapy for ovarian cancer.
Westfall SD; Nilsson EE; Skinner MK
Chemotherapy; 2008; 54(1):67-76. PubMed ID: 18073474
[TBL] [Abstract][Full Text] [Related]
13. Triptolide reverses the Taxol resistance of lung adenocarcinoma by inhibiting the NF-κB signaling pathway and the expression of NF-κB-regulated drug-resistant genes.
Jiang N; Dong XP; Zhang SL; You QY; Jiang XT; Zhao XG
Mol Med Rep; 2016 Jan; 13(1):153-9. PubMed ID: 26531258
[TBL] [Abstract][Full Text] [Related]
14. Plumbagin Suppresses the Invasion of HER2-Overexpressing Breast Cancer Cells through Inhibition of IKKα-Mediated NF-κB Activation.
Kawiak A; Domachowska A
PLoS One; 2016; 11(10):e0164064. PubMed ID: 27727280
[TBL] [Abstract][Full Text] [Related]
15. Triptolide inhibits PDGF-induced proliferation of ASMCs through G0/G1 cell cycle arrest and suppression of the AKT/NF-κB/cyclinD1 signaling pathway.
He S; Chen M; Lin X; Lv Z; Liang R; Huang L
Eur J Pharmacol; 2020 Jan; 867():172811. PubMed ID: 31756335
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of breast cancer resistance protein plays a role in HER2-mediated chemoresistance through PI3K/Akt and nuclear factor-kappa B signaling pathways in MCF7 breast cancer cells.
Zhang W; Ding W; Chen Y; Feng M; Ouyang Y; Yu Y; He Z
Acta Biochim Biophys Sin (Shanghai); 2011 Aug; 43(8):647-53. PubMed ID: 21712253
[TBL] [Abstract][Full Text] [Related]
17. Triptolide (TPL) inhibits global transcription by inducing proteasome-dependent degradation of RNA polymerase II (Pol II).
Wang Y; Lu JJ; He L; Yu Q
PLoS One; 2011; 6(9):e23993. PubMed ID: 21931633
[TBL] [Abstract][Full Text] [Related]
18. Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cells.
Bhat-Nakshatri P; Sweeney CJ; Nakshatri H
Oncogene; 2002 Mar; 21(13):2066-78. PubMed ID: 11960379
[TBL] [Abstract][Full Text] [Related]
19. Triptolide represses oral cancer cell proliferation, invasion, migration, and angiogenesis in co-inoculation with U937 cells.
Yang CY; Lin CK; Lin GJ; Hsieh CC; Huang SH; Ma KH; Shieh YS; Sytwu HK; Chen YW
Clin Oral Investig; 2017 Jan; 21(1):419-427. PubMed ID: 27073100
[TBL] [Abstract][Full Text] [Related]
20. Anti-cancer and Sensibilisation Effect of Triptolide on Human Epithelial Ovarian Cancer.
Hu H; Luo L; Liu F; Zou D; Zhu S; Tan B; Chen T
J Cancer; 2016; 7(14):2093-2099. PubMed ID: 27877225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
